Evidence map›Paper›PMID 38574400›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.

Kristiana Xhima, Julie Ottoy, Erin Gibson, Katherine Zukotynski, Christopher Scott, Ginelle J Feliciano, Sabrina Adamo, Phillip H Kuo, Michael J Borrie, Howard Chertkow and 14 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kristiana XhimaDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-4071-8319
Julie OttoyDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Erin GibsonDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Katherine ZukotynskiDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Christopher ScottDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Ginelle J FelicianoDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Sabrina AdamoDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Phillip H KuoDepartments of Medical Imaging, Medicine, Biomedical Engineering, University of Arizona, Tucson, Arizona, USA.
Michael J BorrieSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Howard ChertkowRotman Research Institute, Baycrest Health Sciences, Toronto, Ontario, Canada.
Richard FrayneDepartments of Radiology and Clinical Neuroscience, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Robert LaforceClinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Quebec City, Quebec, Canada.
Michael D NoseworthyDepartments of Medicine and Radiology, McMaster University, Hamilton, Ontario, Canada.
Frank S PratoSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Demetrios J SahlasDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada.
Eric E SmithDepartment of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Vesna SossiPhysics and Astronomy Department and DM Center for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
Alexander ThielDepartment of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
Jean-Paul SoucyMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Jean-Claude TardifMontreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Maged GoubranDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Sandra E BlackDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Joel RamirezDr. Sandra E. Black Centre for Brain Resilience and Recovery, LC Campbell Cognitive Neurology, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-5582-1776
Medical Imaging Trials Network of Canada (MITNEC)

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
ADNI Department of Defense W81XWH-12-2-0012CIHR 13129CIHR 159910Dr. Sandra Black Centre for Brain Resilience and RecoveryL.C. Campbell FoundationMedical Imaging Trial Network of Canada #NCT02330510NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

introductionCerebral small vessel disease (SVD) and amyloid beta (Aβ) pathology frequently co-exist. The impact of concurrent pathology on the pattern of hippocampal atrophy, a key substrate of memory impacted early and extensively in dementia, remains poorly understood.

methodsIn a unique cohort of mixed Alzheimer's disease and moderate-severe SVD, we examined whether total and regional neuroimaging measures of SVD, white matter hyperintensities (WMH), and Aβ, as assessed by

resultsFrontal WMH, occipital WMH, and Aβ were independently associated with smaller hippocampal volume. Frontal WMH had a spatially distinct impact on hippocampal shape relative to Aβ. In contrast, hippocampal shape alterations associated with occipital WMH spatially overlapped with Aβ-vulnerable subregions. DISCUSSION: Hippocampal degeneration is differentially sensitive to SVD and Aβ pathology. The pattern of hippocampal atrophy could serve as a disease-specific biomarker, and thus guide clinical diagnosis and individualized treatment strategies for mixed dementia.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesCerebral Small Vessel DiseasesHippocampusPositron-Emission TomographyAgedAged, 80 and overAtrophyCohort StudiesFemaleHumansMagnetic Resonance ImagingMaleNeuroimagingWhite MatterAmyloid beta-PeptidesAlzheimer's diseaseamyloidbiomarkercerebral small vessel diseasehippocampal shapehippocampal volumeMedical Imaging Trials Network of Canada C6 Projectmixed dementianeurodegenerationvascularwhite matter hyperintensities

Identifiers

PMID38574400
PMCPMC11095424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.